Access + Capital + Execution = Outcomes
From narrative to revenue — aligning science, capital, and execution to deliver outcomes. We pair capital strategy and narrative with commercialization execution to create asymmetric outcomes.
Inflection points demand
disproportionate value.
We work with founders, investors, and institutions at inflection points — where the right decisions unlock disproportionate value.
Building at the intersection of science, AI, and capital to unlock outsized results.
Network × Depth × Execution
Stanford & Silicon Valley
Embedded in the Stanford and Silicon Valley ecosystem with deep institutional relationships.
StartX & Y Combinator
Connected across StartX and Y Combinator networks — accessing founders, investors, and operators.
Scientific Advisors
Access to a global network of scientific advisors across indications and therapeutic areas.
VC, Pharma & Clinical
Deep relationships across venture capital, pharma, and clinical institutions that drive outcomes.
"We don't just advise — we activate networks that move deals forward."
What we deliver
End-to-end strategic advisory at the intersection of science, capital, and execution.
Capital Strategy & Fundraising
- Narrative, numbers & network alignment
- Pitch deck development
- Fundraising process advisory
- Relationship-based investor matching
- Pitch coaching
Investor Readiness & Strategic Positioning
- Investor readiness
- Competitive analysis
- Opportunity sourcing
- New venture design
- Talent strategy
- Diligence support
Pharma & Biotech Partnerships
- Pharma & biotech partnerships
- Clinical commercialization strategy
- KOL & institutional engagement
- Trial-to-market pathways
- Scientific-to-commercial translation
- Licensing & co-development
AI & Data Strategy
- Data monetization strategy
- AI-enabled commercial optimization
- Workflow automation
- Decision intelligence integration
Deal Strategy & Execution
- Deal strategy
- Financial modeling
- Deal structuring
- Capital strategy
- Strategic forecasting
Business Development
- Licensing & deal structuring
- Commercialization strategy
- Revenue pathway design
The people behind the outcomes
Adrianna Davies
Adrianna Davies is a serial life sciences entrepreneur and strategic advisor focused on creating asymmetric outcomes at the intersection of science, AI, and capital. She works with founders, investors, and institutions to identify choke points, unlock leverage, and translate complex technologies into scalable, financeable companies.
As Founder and CEO of StrandSmart Inc., she built a precision diagnostics platform centered on genomic insights and clinical utility. She was previously part of Qurasense Inc., a Y Combinator and StartX Med-backed company developing non-invasive diagnostics for women's health. Earlier, she co-founded Sparkup Inc., a platform accelerating technology transfer from academic research into commercial life sciences applications, acquired in 2015.
She holds a degree in Political Science, Business, and Philosophy from McGill University. Fluent in English, Portuguese, French, Spanish — and Investor — Adrianna brings global perspective, pattern recognition, and execution intensity to every engagement.
Mark Myslinski
Mark Myslinski is a senior life sciences operator with deep expertise in commercializing diagnostics, building revenue engines, and scaling CLIA-based businesses. His career spans venture-backed startups to Fortune 100 companies, with a consistent focus on translating scientific innovation into adopted, reimbursed, and revenue-generating products.
At AMD Advisor, Mark focuses on go-to-market strategy, clinical adoption, reimbursement pathways, and commercialization execution — ensuring that novel technologies not only work, but win in real-world healthcare markets.
He has held multiple senior commercial leadership roles, including Chief Commercial Officer at KEW, Inc., Senior Vice President and Chief Commercial Officer at Saladax Biomedical, and served on the Board of MDxHealth (NASDAQ: MDXH). He currently chairs the Moravian University Leadership Council.
Deeply embedded relationships
We leverage deeply embedded relationships across the global life sciences ecosystem.